![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Fraimout N.
Publisher: Springer Publishing Company
ISSN: 1776-2596
Source: Targeted Oncology, Vol.3, Iss.4, 2008-10, pp. : 265-267
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Capalbo Silvana Chiefa Antonia Delia Mario Diomede Daniela Liso Vincenzo
Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bortezomib in mantle cell lymphoma
Future Oncology, Vol. 4, Iss. 2, 2008-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The Role of Bortezomib in the Treatment of Lymphoma
By Barr Paul Fisher Richard Friedberg Jonathan
Cancer Investigation, Vol. 25, Iss. 8, 2007-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bortezomib in the Treatment of Cancer
Recent Patents on Anti-Cancer Drug Discovery, Vol. 1, Iss. 3, 2006-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Hairy Cell Leukemia: Established and Novel Approaches to Treatment
American Journal of Cancer, Vol. 1, Iss. 3, 2002-03 ,pp. :